Amanote Research
Register
Sign In
PHP149 Perception of Pharmaceutical Companies on the Drug Price-Volume Negotiation in South Korea
Value in Health
- United Kingdom
doi 10.1016/j.jval.2011.08.699
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2011
Authors
E.S. Kim
B.J. Lee
E.K. Lee
Publisher
Elsevier BV
Related search
Differential Completeness of Spontaneous Adverse Event Reports Among Hospitals/Clinics, Pharmacies, Consumers, and Pharmaceutical Companies in South Korea
PLoS ONE
Multidisciplinary
Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Effect of Internal and External Factors on the Stock Price of Pharmaceutical Companies in Emerging and Emerged Markets
Differential Effects of Two Pharmaceutical Cost Containment Policies on Outpatient Prescription Drug Expenditures in Korea
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pharmaceutical Policy Reforms to Regulate Drug Prices in Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea
Value in Health Regional Issues
Finance
Pharmacology
Economics
Health Policy
Toxicology
Econometrics
Pharmaceutics
Small Pharmaceutical Companies
Organic Process Research and Development
Organic Chemistry
Theoretical Chemistry
Physical
International Best Practices for Negotiating 'Reimbursement Contracts' With Price Rebates From Pharmaceutical Companies
Health Affairs
Medicine
Health Policy
Profitability of Pharmaceutical Companies in the Visegrád Countries
Montenegrin Journal of Economics
Economics
Econometrics
Finance
Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
Journal of Young Pharmacists
Toxicology
Pharmaceutics
Pharmacology
